Process Validation Strategy Templates | IVT - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Process Validation Strategy Templates | IVT


Validation Week

IVT’s 19th Annual
Validation Week

October 22-24, 2013
San Diego, California

Brochure | Register


More in GMPs/Validation

Getty Images

This strategy/validation plan defines what needs to be validation (i.e. equipment, systems, and processes) and how validation needs will be met for a given project. 

The strategy also provides a roadmap to follow ensuring the requirements are defined and agree upon up-front and that all requirements are met prior to implementation or launch.

Download the Master Validation Plan Template

Download the Validation Report Template 

Download the Process Validation Readiness Guidelines

Download the accompanying presentation,"Best Practice to Implement Process Validation in Device Manufacturing Enterprise-wide," presented at IVT's 18th Annual Validation Week, Philadelphia, PA, October 2012

This article was originally published in IVT - read original article: Process Validation Strategy Templates | IVT


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: IVT,
Click here